Moderna
MRNA
#1601
Rank
HK$81.62 B
Marketcap
HK$211.13
Share price
-0.62%
Change (1 day)
-74.61%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -HK$27.95 Billion

According to Moderna 's latest financial reports the company's current earnings are HK$3.19 Billion. , an increase over its 2023 earnings that were of -HK$30.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -HK$27.8 Billion-8.22%
2023 -HK$30.29 Billion-140.65%
2022 HK$74.49 B-27.81%
2021 HK$103.18 B-1911.15%
2020 -HK$5.7 Billion44.7%
2019 -HK$3.94 Billion28.63%
2018 -HK$3.07 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.36 Billion-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$164.49 B-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.33 Billion-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.83 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$105.80 B-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$4.66 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$135.29 B-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.92 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA